WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ligand Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen L. SabbaDirector2026-03-231,000$207.87
$207.87kSell
Octavio EspinozaChief Financial Officer2026-03-112,405$92.65
$222.82kBuy
Octavio EspinozaChief Financial Officer2026-03-113,057$225.00
$687.83kSell
Andrew ReardonCLO Secretary2026-03-04100$199.01
$19.90kSell
Andrew ReardonCLO Secretary2026-03-041,446$208.12
$300.94kSell
Andrew ReardonCLO Secretary2026-03-04612$207.01
$126.69kSell
Andrew ReardonCLO Secretary2026-03-04340$206.37
$70.16kSell
Andrew ReardonCLO Secretary2026-03-04460$205.18
$94.38kSell
Andrew ReardonCLO Secretary2026-03-04200$204.17
$40.83kSell
Andrew ReardonCLO Secretary2026-03-045,000$52.27
$261.35kBuy

1 of 12

LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LGND insiders and whales buy or sell their stock.

LGND Shareholders

What type of owners hold Ligand Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P317.61%63,334,719$12.38BInsider
David M. Knott63.24%12,611,277$2.47BInsider
Daniel S. Loeb48.92%9,754,756$1.91BInsider
Investment 10 LLC17.96%3,582,065$700.22MInsider
Blackrock Inc14.74%2,940,231$574.76MInstitution
Vanguard Group Inc10.40%2,073,892$405.40MInstitution
Janus Henderson Group PLC4.99%995,400$194.58MInstitution
State Street Corp3.77%751,205$146.85MInstitution
Goldman Sachs Group Inc3.44%686,330$134.16MInsider
Nomura Asset Management International Inc3.23%644,093$125.91MInstitution

1 of 3

LGND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LGND18.32%81.68%Net SellingNet Selling
CNTA91.12%8.88%Net BuyingNet Selling
CORT28.22%71.78%Net BuyingNet Buying
ACAD72.02%27.98%Net SellingNet Selling
CRNX89.56%10.44%Net BuyingNet Selling
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Ownership FAQ

Who owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals (NASDAQ: LGND) is owned by 103.11% institutional shareholders, 459.65% Ligand Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Ligand Pharmaceuticals shareholder, owning 63.33M shares representing 317.61% of the company. Bvf Partners L P's Ligand Pharmaceuticals shares are currently valued at $12.20B.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.